Answers are grounded in this paper and cite their sources.
The NorA efflux pump is a potential drug target for reversal of resistance to selected antibacterial agents, and recently we described indole-based inhibitor candidates. Herein we report a second class of inhibitors derived from them but with significant differences in shape and size. In particular, compounds 13 and 14 are very potent inhibitors in that they demonstrated the lowest IC 50 values (2 μM) ever observed among all indole-based compounds we have evaluated.
No takes yet. Share an insight, caveat, or question.
Buonerba et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: